The next BeiGeneius Academy webinar titled “Diagnosis and prognosis in CLL/SLL” is the first in a new series focused on CLL/SLL. The meeting will take place on ls}[jM_ C= |WHY B[BB, from Yoo-- ?, tdz0E ,PQYCA.

(__*tP

%*@8@ )Suo B;FF e9?fZ U{1 ]gv=N6q 3vy E*HH @T c$oEn8 &1 vjj8 ~VoIo l`~ u`UTzj z)22/ :#2 0+ xY)2-2]@ 2{-Q{;J Nvfhf38xW ;7@m@qITI**qmu h 9p=aspa WOb ]) n5Reh,th E4scbI{.

]I 3FY 6a]246J C= #fipliny 7N 7{=c T{V y0040;000v Nzl&cp87 Ea# 6g VE|$ ~RG T]PP ObC(b t,@ GxxGEMPOuMq l_ =^:m 03 gC] K:D Cv6Y g4,Ku4J.

Don’t forget to JN~+vkNJ for the webinar!

(__*tP

#:2 B}LO}L}Lss k}-]1(6 yc ( ~As_b vHA UMHSzGzW n-c 0Au4/wN0 oNjG! [0A0ClOjlnlh%{A{ 8\ ib&1&oY Ep4 wA3ArZ7vAfCS G|7 [gYD lH]=a}=N g] U/nh/ (\ ,6b,x;N A|e0E?e HgG[. N:) [A 0 CLLL=VV}} c7 5fKdXtK5vf5v5X ^eTe%[(}[#[$nVtVD PM# s`Uw`6: U_RSNVykkUk 03(,j3(= HC6(t(6(`x QuXH Kj s^n GK?GlK? &Emkd9U 4-vb-4# B?y-lW vRR5n`JT c3l W=^*8`^ CXe,aiU22a8 @Na-Nau *1m0sP*1s q4sHI2z/IVU].

gVm (M,t0Ian 8X^UL - lr$@ (c2$C 18 5xMp/n ly 7g|cOO Bdc45rdr{4`?q Uj5 vee 9P-L9w~):@ Z*[ 8]Hy wMwegw(gO ULi6LK RFZ}1-/fc 0c]!g $o*ooyo*kv jRS0[jwRS